Literature DB >> 15517984

Characterization of toxin complex produced by a unique strain of Clostridium botulinum serotype D 4947.

Kimiko Hasegawa1, Toshihiro Watanabe, Hiroaki Sato, Yoshimasa Sagane, Shingo Mutoh, Tomonori Suzuki, Akihito Yamano, Hirokazu Kouguchi, Kouichi Takeshi, Arihide Kamaguchi, Yukako Fujinaga, Keiji Oguma, Tohru Ohyama.   

Abstract

A unique strain of Clostridium botulinum, serotype D 4947 (D-4947), produces a considerable amount of a 650 kDa toxin complex (L-TC) and a small amount of a 280 kDa M-TC, a 540 kDa TC, and a 610 kDa TC. The complexes are composed of only un-nicked components, including neurotoxin (NT), nontoxic nonhemagglutinin (NTNHA) and hemagglutinin subcomponents (HA-70, HA-33 and HA-17). Unlike other NTs from all serotype strains, separation of D-4947 NT from L-TC, except for M-TC, during chromatography required highly alkaline conditions around pH 8.8. The separated NT and NTNHA/HAs complex can be reconstituted to L-TC that is indistinguishable from the parent L-TC with respect to toxicity, hemagglutination activity and gel filtration profile. The isoelectric points of NT and NTNHA/HAs were close together depending on the number of HA-33/17 molecules. We have established a new method to separate the unique D-4947 NT from the complex, which will yield valuable information on structure of botulinum toxin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517984     DOI: 10.1023/b:jopc.0000039551.42676.4c

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  20 in total

1.  In vitro reconstitution of the Clostridium botulinum type D progenitor toxin.

Authors:  Hirokazu Kouguchi; Toshihiro Watanabe; Yoshimasa Sagane; Hiroyuki Sunagawa; Tohru Ohyama
Journal:  J Biol Chem       Date:  2001-11-16       Impact factor: 5.157

2.  Botulinum neurotoxin types B and E: purification, limited proteolysis by endoproteinase Glu-C and pepsin, and comparison of their identified cleaved sites relative to the three-dimensional structure of type A neurotoxin.

Authors:  S Prabakaran; W Tepp; B R DasGupta
Journal:  Toxicon       Date:  2001-10       Impact factor: 3.033

3.  Spontaneous nicking in the nontoxic-nonhemagglutinin component of the Clostridium botulinum toxin complex.

Authors:  Yoshimasa Sagane; Toshihiro Watanabe; Hirokazu Kouguchi; Hiroyuki Sunagawa; Shigehiro Obata; Keiji Oguma; Tohru Ohyama
Journal:  Biochem Biophys Res Commun       Date:  2002-03-29       Impact factor: 3.575

4.  Effect of pH on the stability of type-C toxin of Clostridium botulinum.

Authors:  J Halouzka; Z Hubálek
Journal:  Folia Microbiol (Praha)       Date:  1992       Impact factor: 2.099

5.  Production and purification of Clostridium botulinum type C and D neurotoxin.

Authors:  F Gessler; H Böhnel
Journal:  FEMS Immunol Med Microbiol       Date:  1999-07

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E.

Authors:  G Schiavo; O Rossetto; S Catsicas; P Polverino de Laureto; B R DasGupta; F Benfenati; C Montecucco
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

8.  Molecular composition of progenitor toxin produced by Clostridium botulinum type C strain 6813.

Authors:  T Watanabe; Y Sagane; H Kouguchi; H Sunagawa; K Inoue; Y Fujinaga; K Oguma; T Ohyama
Journal:  J Protein Chem       Date:  1999-10

Review 9.  Neurotoxins affecting neuroexocytosis.

Authors:  G Schiavo; M Matteoli; C Montecucco
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

Review 10.  Mechanism of action of tetanus and botulinum neurotoxins.

Authors:  C Montecucco; G Schiavo
Journal:  Mol Microbiol       Date:  1994-07       Impact factor: 3.501

View more
  9 in total

1.  Crystallization and preliminary X-ray analysis of the Clostridium botulinum type D nontoxic nonhaemagglutinin.

Authors:  Keita Miyata; Ken Inui; Shin-Ichiro Miyashita; Yoshimasa Sagane; Kimiko Hasegawa; Takashi Matsumoto; Akihito Yamano; Koichi Niwa; Toshihiro Watanabe; Tohru Ohyama
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-01-27

2.  Reversible Association of the Hemagglutinin Subcomplex, HA-33/HA-17 Trimer, with the Botulinum Toxin Complex.

Authors:  Yoshimasa Sagane; Shingo Mutoh; Ryosuke Koizumi; Tomonori Suzuki; Shin-Ichiro Miyashita; Keita Miyata; Tohru Ohyama; Koichi Niwa; Toshihiro Watanabe
Journal:  Protein J       Date:  2017-10       Impact factor: 2.371

3.  Random phage display-based screening of peptides that bind to botulinum neurotoxin binding protein, nontoxic nonhemagglutinin.

Authors:  Yoshimasa Sagane; Keita Miyata; Sayuri Kurihara; Tohru Yoneyama; Ken Inui; Shin-Ichiro Miyashita; Shintaro Hayashi; Tomonori Suzuki; Koichi Niwa; Toshihiro Watanabe
Journal:  Curr Microbiol       Date:  2013-03-16       Impact factor: 2.188

4.  Purification and characterization of nontoxic protein complex from serotype D 4947 botulinum toxin complex.

Authors:  Keita Miyata; Yoshimasa Sagane; Ken Inui; Shin-Ichiro Miyashita; Tomonori Suzuki; Keiji Oguma; Tohru Ohyama; Koichi Niwa; Toshihiro Watanabe
Journal:  Protein J       Date:  2012-06       Impact factor: 2.371

5.  Effect of nicking the C-terminal region of the Clostridium botulinum serotype D neurotoxin heavy chain on its toxicity and molecular properties.

Authors:  Tomonori Suzuki; Hirokazu Kouguchi; Toshihiro Watanabe; Kimiko Hasegawa; Tohru Yoneyama; Koichi Niwa; Atsushi Nishikawa; Jae-Chul Lee; Keiji Oguma; Tohru Ohyama
Journal:  Protein J       Date:  2007-04       Impact factor: 4.000

6.  Botulinum toxin complex increases paracellular permeability in intestinal epithelial cells via activation of p38 mitogen-activated protein kinase.

Authors:  Shin-Ichiro Miyashita; Yoshimasa Sagane; Ken Inui; Shintaro Hayashi; Keita Miyata; Tomonori Suzuki; Tohru Ohyama; Toshihiro Watanabe; Koichi Niwa
Journal:  J Vet Med Sci       Date:  2013-07-25       Impact factor: 1.267

7.  Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents.

Authors:  Jerry O Conway; Laura J Sherwood; M Thelma Collazo; John A Garza; Andrew Hayhurst
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

8.  "Non-Toxic" Proteins of the Botulinum Toxin Complex Exert In-vivo Toxicity.

Authors:  Shin-Ichiro Miyashita; Yoshimasa Sagane; Tomonori Suzuki; Takashi Matsumoto; Koichi Niwa; Toshihiro Watanabe
Journal:  Sci Rep       Date:  2016-08-10       Impact factor: 4.379

9.  Building-block architecture of botulinum toxin complex: Conformational changes provide insights into the hemagglutination ability of the complex.

Authors:  Tomonori Suzuki; Yoshimasa Sagane; Takashi Matsumoto; Kimiko Hasegawa; Akihito Yamano; Koichi Niwa; Toshihiro Watanabe
Journal:  Biochem Biophys Rep       Date:  2016-11-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.